Trial information
A Study of NT-Pro Brain Natriuretic Peptide (NT-proBNP) in Patients With Acute Heart Failure.
Status: Recruiting
Protocol number: BOT_1
Company division: Diagnostic
Official Scientific Title: NT-proBNP in the optimization of treatment after recent acute heart failure (BOT-Acute HF) trial.
Brief summary: This study will assess whether measurement of NT-proBNP levels before discharge from hospital after acute heart failure improves the prognosis of patients, with respect to major cardiovascular events (cardiovascular hospitalizations and cardiac deaths).
Study type: Interventional; Randomized; Open Label; Parallel study
Condition: Heart Failure
Intervention type: Diagnostic Test
Intervention name: ELECSYS®proBNP
Inclusion criteria:
- adult patients, >=18 years of age;
- hospital admission for acute heart failure, class III or IV;
- requirement for intravenous therapy.
Exclusion criteria:
- clinical or laboratory evidence of an acute coronary syndrome;
- major arrhythmias as the main cause of symptoms;
- PTCA or CABG planned in next 3 months;
- non-cardiac concomitant diseases which may have an important influence on outcome as primary factor.
Gender: Males or Females
Age limits: Min: 18 Years Max: N/A (No limit)
Accepts healthy volunteers: No
Anticipated start date: July, 2006
Trial registration date: 08/22/2007
Date last updated: 10/15/2008
Link to trial result
This trial is being conducted at the following locations:
Italy
